Multimodal Intervention for Bipolar Disorder
(BTBD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist individuals with bipolar disorder in transitioning smoothly from the hospital back to their community. It combines group learning sessions (Group-Based Psychoeducation), peer support, and guidance for local healthcare providers (Personalized Support for Community Healthcare Providers) to enhance understanding of the illness and improve symptom management. The trial is ideal for those diagnosed with bipolar disorder in the last two years who have faced challenges such as psychosis (a mental health condition affecting thoughts and perceptions) or difficulty understanding their illness. Participants should be comfortable communicating in English. As an unphased trial, this study offers a unique opportunity to contribute to innovative approaches in managing bipolar disorder.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on adding support like group education and peer support, so it's likely you can continue your current treatment.
What prior data suggests that this multimodal intervention is safe for individuals with bipolar disorder?
Research has shown that the components of the treatment in this study have been safe and well-received in the past. Group-based psychoeducation, where individuals learn together about managing bipolar disorder, has been found to reduce the likelihood of hospitalization. It also enhances feelings of support and understanding about the condition.
Peer support, where individuals with similar experiences assist each other, has demonstrated small positive effects on recovery. Some studies suggest it might not alter symptom severity, but it can enhance social connection.
Lastly, personalized support for healthcare providers has been linked to improved patient care. This involves guiding healthcare providers on better supporting individuals with bipolar disorder, leading to improved mental health outcomes.
Overall, these treatments have shown good results in other studies, indicating they are safe options.12345Why are researchers excited about this trial?
Researchers are excited about this multimodal intervention for bipolar disorder because it combines several supportive strategies to enhance patient care. Unlike standard treatments, which often focus solely on medication, this approach includes group-based psychoeducation, encouraging patients to learn collaboratively about managing their condition. Additionally, the intervention offers biweekly peer support, providing individuals and families with a community to share experiences and insights. Finally, it includes personalized clinical guidance for community healthcare providers, aiming to tailor care more closely to each patient's needs. This comprehensive strategy could lead to more effective and holistic management of bipolar disorder.
What evidence suggests that this trial's treatments could be effective for bipolar disorder?
This trial will evaluate a Multi-Modal Transitional Care Intervention for bipolar disorder, which includes group-based psychoeducation, peer support, and personalized support for community healthcare providers. Research has shown that group-based education sessions can significantly help people with bipolar disorder by reducing relapse rates and extending the time between episodes. Peer support aids recovery by helping individuals manage better and feel more in control. Personalized support from healthcare providers enhances mental health by improving quality of life. Together, these elements aim to prevent hospital readmissions and support smoother transitions from hospital to community care.23678
Are You a Good Fit for This Trial?
This trial is for individuals with bipolar disorder, specifically those who have recently been discharged from the hospital and are in the early stages of their condition. Participants should be seeking to improve treatment adherence and symptom management.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Psychoeducation
Participants attend 6 clinician-facilitated group psychoeducation sessions
Peer Support
Participants receive biweekly one-on-one peer support sessions
Provider Support
Personalized support for participants' primary healthcare providers with two collaborative sessions
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Group-Based Psychoeducation
- Peer Support
- Personalized Support for Community Healthcare Provider
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
St. Joseph's Healthcare Hamilton
Collaborator